News

Oncodesign Precision Medicine (OPM) and Navigo Proteins GmbH have partnered to develop radiotheranostics, a targeted therapy that delivers radioactivity...

Bristol Myers Squibb’s Breyanzi has received accelerated FDA approval for adult patients with relapsed or refractory follicular lymphoma who...

Moffitt Cancer Center and Fulgent Pharma have formed a partnership to accelerate the development of personalized cancer therapies. •...

Syros Pharmaceuticals focused on hematologic malignancies and provided updates on its clinical progress, including the passing of the interim...

Alto Neuroscience has initiated a Phase 2 study of ALTO-203, a PDE4 inhibitor targeted at patients with major depressive...

Medidata, a leading clinical trial solutions provider, has partnered with Worldwide Clinical Trials (Worldwide) to leverage Medidata AI. This...

Oklo Inc., a provider of clean nuclear power and fuel recycling, has partnered with Atomic Alchemy Inc. to meet...

Empatica, a digital biomarker development and patient monitoring company, has integrated McRoberts’ 71 endpoints into its FDA-cleared Health Monitoring...

Baxter International has received FDA approval to expand the use of Clinolipid, a lipid emulsion, to include pediatric patients,...

Can-Fite BioPharma has secured approval from the FDA and EMA for a pivotal Phase 3 clinical trial for the...